The eight-year loan is unsecured and in line with the Nordic Investment Bank lending strategy to promote social sustainability in the Nordic countries. The loan is linked to the development of the Patienten 1 property in Hagastaden, Stockholm, Sweden. The property which in addition to accommodating the new St Erik Eye Hospital, will become a centre for business, research and education in eye research and care. Hemsö’s jointly owned company, Vitartes, is developing the project.
“This long-term financing is very attractive for us as it will extend Hemsö’s overall loan maturity in our Swedish loan portfolio, which has proved challenging in the Swedish bond market. We are also proud that Hemsö is able to further diversify its investor base with a new lender that supports the company’s focus on social infrastructure and Life Science,” says Nils Styf, CEO of Hemsö.
“NIB is an international financial institution owned by Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway and Sweden. The bank has lending operations both in and outside its member countries. NIB’s vision is a successful and sustainable Nordic-Baltic region. NIB finances projects that improve competitiveness and the environment of the Nordic and Baltic countries.”